News and analysis on diagnostic technologies and applications.
Big data, automation, and low-tech changes to workspaces have combined to reduce ARUP's incidences of lost lab specimens.
The DOJ alleged Biotheranosics promoted and performed its Breast Cancer Index test for patients who had not been in remission for five years and who had not been taking tamoxifen.
The approval expands the firm's product range now available to European customers.
In a rapidly growing industry where 14 new genetic tests are launched daily, tracking utilization and payment is increasingly difficult, Concert Genetics' report says.
PartoSure includes a noninvasive strip test that detects placental alpha microglobulin in patients and is already being used in 35 countries in Europe, the Middle East, Asia, and Latin America.
